Allazo is the Greek word for “change,” a fitting name for a company that’s been built to transform an industry where the potential for using data analytics has been largely untapped.
Founded and led by healthcare and technology experts from leading organizations such as CVS Health, Boston Consulting Group, Bain and Company, Anthem, and FTI Consulting, AllazoHealth combines AI technology and strategic acumen to realize the potential of AI to drive sustainable advancement in healthcare.
Back to top
SCroll down
MM+M’s annual Game Changers highlights an all-new survey of health execs on what areas of innovation leaders should invest in next year to prepare for 2025.
Culture
Leveraging patient-level data from both the customers’ data sources as well as our own database of more than 25 million patient records, AllazoHealth is validated to drive 5.5x greater adherence uplift compared to traditional programs; a 2.3x uplift in fill rate; and a 13% increase in days on therapy.
At the same time, we help customers and partners achieve these results while delivering, on average, 25% cost savings in the process.
The Factoid
Contact Us
The pharmaceutical industry spends billions annually on patient support programs and marketing aimed at patients to start and stay
on therapy. Unfortunately, research shows that these initiatives are largely unsuccessful.
The rise of AI-driven personalization can make a difference through enhanced patient experiences. A tailored experience is more effective for engagement, optimizes medication adherence behaviors, improves
patient outcomes, and powers more efficient operations.
Insight
Logo
Through our award-winning AI platform and patient-level intent data, AllazoHealth empowers pharmaceutical manufacturers that engage with patients to personalize interventions and create the optimal engagement experience for each individual, maximizing the impact and efficiency of patient support programs and pharmaceutical marketing.
AllazoHealth’s AI uniquely empowers you to tailor and optimize your programs through more individualized outreach, a major upgrade from persona-based targeting.
Appetite for Disruption
We envision a world where healthcare journeys are truly personalized, creating engaging experiences that deliver better outcomes through AI.
Company Value
